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Background: The assessment of therapeutic adherence is essential for accurately interpreting
treatment outcomes in psychotherapy research. However, such assessments are often
neglected. Aims: To fill this gap, we aimed to develop and test a scale that assessed therapeutic
adherence to Cognitive Processing Therapy – Cognitive Only (CPT), which was adapted
for a treatment study targeting patients with post-traumatic stress disorder and co-occurring
borderline personality symptoms. Method: Two independent, trained raters assessed 30
randomly selected treatment sessions involving seven therapists and eight patients who were
treated in a multicentre randomized controlled trial. Results: The inter-rater reliability for all
items and the total score yielded good to excellent results (intraclass correlation coefficient
[ICC] = 0.70 to 1.00). Cronbach’s α was .56 for the adherence scale. Regarding content
validity, three experts confirmed the relevance and appropriateness of each item. Conclusion:
The adherence rating scale for the adapted version of CPT is a reliable instrument that can be
helpful for interpreting treatment effects, analysing possible relationships between therapeutic
adherence and treatment outcomes and teaching therapeutic skills.
Keywords: Post-traumatic stress disorder, PTSD, cognitive processing therapy, CPT,
therapeutic adherence, treatment integrity
Introduction
Monitoring treatment integrity, which ensures that a treatment was implemented as intended,
is often missing from treatment studies (Moncher and Prinz, 1991; Waltz et al., 1993;
Perepletchikova et al., 2007). In addition to securing internal validity, treatment integrity
is important as a potential mediator for evaluating the effectiveness of a specific treatment
(Weck et al., 2011a). Thus such monitoring may facilitate identifying the most important
therapeutic skills for a specific treatment and integrating them into therapist training and
education (Perepletchikova and Kazdin, 2005). Similar to therapeutic competence and
treatment differentiation, therapeutic adherence is an important part of treatment integrity.
Therapeutic adherence is defined as the extent to which a therapist applies interventions as
they are described in the treatment manual (Waltz et al., 1993). Generally, separate assessment
of therapeutic adherence and competence is recommended to help distinguish between the two
constructs, which often are confused (Dobson and Singer, 2005; Barber et al., 2007).
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Four different types of therapist behaviour should be included in adherence measurement:
(1) ‘therapist behaviours that are unique to that treatment modality and essential to it’ (e.g.
behavioural experiments in the treatment of social phobia); (2) ‘behaviours that are essential
to the treatment but not unique to it’ (e.g. cognitive techniques); (3) ‘behaviours that are
compatible with the specified modality, and therefore not prohibited, but neither necessary nor
unique’ (e.g. chatting at the beginning of a session); and (4) ‘behaviours that are proscribed’
(e.g. exposure elements in an exclusively cognitive treatment) (Waltz et al., 1993; pp. 624–
625).
In addition to providing a treatment manual, adequate training of the therapists and regular
supervision, assessment by independent observers is recommended to ensure treatment
adherence (Weck et al., 2011a). A common method for assessing adherence is to rate video
or audio recordings, in which different treatment elements (items) are specified for each
session (e.g. Resick et al., 2008; Gutermann et al., 2015). The rater assesses whether these
specified interventions have occurred (e.g. did the therapist deliver the designated content
of session one: yes or no?). Other studies have focused on the assessment of more global
therapeutic adherence independent of the content of the specific treatment session. Thus for
every session, the same items that reflect more global adherence are rated, such as ‘time
management’, ‘agenda’ or ‘addressing problematic behaviour’. This method is particularly
useful for therapies with flexible, modular interventions tailored to the individual patient, and
it allows for the rating of randomly selected videos, which is less time consuming (e.g. Barber
et al., 2007).
However, both methods require highly qualified raters, which imply high costs. Therefore,
despite the importance of assessing treatment integrity, many studies fail to do so. When
adherence is assessed, adequate measures are often missing, or the respective scales are
not tested for their psychometric properties. Generally, few studies on post-traumatic stress
disorder (PTSD) analyse therapeutic adherence (Barber et al., 2007). For one of the most
effective and frequently evaluated PTSD treatments, cognitive processing therapy (CPT;
Resick et al., 2010), therapeutic adherence is often measured and described. Nevertheless,
the psychometric properties of the instruments used have not yet been reported (e.g. Resick
et al., 2008).
In CPT (Resick et al., 2008), the therapist first aims to identify and change dysfunctional
beliefs related to the trauma, such as self-blame (e.g. ‘It was my fault that he raped me’).
Patients gradually learn to challenge their beliefs through Socratic questioning and the use
of worksheets, with the goal of generating more balanced statements and reducing negative
emotions.
Patients with PTSD after childhood sexual/physical abuse (CSA/CPA) typically exhibit
severe psychopathology and several co-morbid diagnoses (Green et al., 2010). This fact is
often neglected in treatments (e.g. Steil et al., 2011). Accordingly, we modified the original
CPT protocol by adding sessions, thus providing additional time within the CPT protocol
to address specific co-morbid symptoms of patients with complex trauma histories. For
this adaptation, we developed the Adherence Rating Scale for CPT (ARS-CPT), which
solely assessed therapeutic adherence by rating video recordings of therapy sessions. This
novel adherence scale combines items that refer to global therapeutic adherence with items
that assess aspects of session-specific adherence. This study tested the newly developed scale
to determine its psychometric properties by examining its inter-rater reliability and internal
consistency. We also tested whether our items represent all facets of the CPT using ratings by
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The data for this study were obtained from a clinical multicentre randomized controlled
trial (RCT) that compared the use of CPT with Dialectical Behaviour Therapy to treat
PTSD in patients with PTSD and borderline personality symptoms (German Clinical Trials
Registration ID: DRKS00006095). The inclusion criteria for the RCT were PTSD after
CSA/CPA according to the structured clinical interview of DSM-IV (SKID I; Wittchen
et al., 1997) plus at least three criteria for borderline personality disorder (BPD). Each
treatment consisted of 45 sessions within a 1-year period (for additional details, see
www.traumatherapie-verbund.de). The original CPT was adapted as follows: four sessions
focused on establishing rapport and developing emergency plans are followed by the 12
original CPT sessions. Subsequently, individual topics related to the trauma are addressed
in 29 additional sessions.
Adherence rating scale for CPT
We determined to develop a new rating scale for assessing therapeutic adherence based on the
adapted CPT treatment manual and orientated on the original CPT Therapists’ Adherence
Protocol – Revised (Mcdonald et al., 2014). We included parts (the adherence ratings)
of the original CPT Therapists’ Adherence Protocol – Revised (items 4–6; for a detailed
description, see Resick et al., 2008), which is a session-specific checklist that assesses whether
interventions occurred for ‘unique and essential elements specific to each session, essential
but not unique elements, acceptable but not necessary elements, and proscribed elements’
(Resick et al., 2008, p. 249) in each of the 12 original CPT sessions. We also developed
a corresponding checklist applicable for the 29 additional more flexible sessions in our
manual.
Additionally, together with a small group of experts in CPT treatment, we developed six
new items (items 1–3, 7–10) that, in contrast to the original CPT Therapists’ Adherence
Protocol, refer to more global therapeutic adherence and are applicable to each treatment
session, which enables random selection of the treatment sessions to be rated. These items
are essential for our adapted CPT protocol, which includes more flexible sessions addressing
individual topics related to the trauma. The items are rated using a 3-point Likert scale with
0 (not adherent), 1 (partly implemented/adherent to some extent) and 2 (adherent), with
descriptions of adherent and non-adherent behaviour based on the manual for our adapted
CPT protocol.
Item 10 assesses global adherence in the therapy session using a 7-point Likert scale from
0 (not adherent) to 6 (very adherent).
Applying our new scale, we combined both approaches as described to assess adherence
specified for each treatment session while considering unique elements for each session
(orientated on the original CPT Therapists’ Adherence Protocol – Revised) and global
adherence (newly developed items). We thereby developed a rating scale that is flexible,
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simple to use and applicable to each of the 41 treatment sessions (except the first four
sessions). Thus our scale enables a broader application to CPT variations that differ in length
and flexibility from the original protocol.
Content validation
Three CPT experts were asked to evaluate the relevance and appropriateness of the ARS-
CPT items using a 4-point Likert scale from 0 (not at all relevant/appropriate) to 3 (extremely
relevant/appropriate). Although the experts were not involved in the video ratings, two of them
worked as supervisors in the treatment study.
Raters
The two raters, with 3 and 8.5 years of clinical experiences, respectively, had received
intensive training (36 h) in CPT by its developer P. Resick. Both raters had treated patients
with CPT under supervision and were involved in the development of the new adherence scale;
they did not participate in the supervision of the therapists during the study. Three pilot cases
were evaluated and discrepancies discussed before starting the assessments for this study.
To avoid drifting apart during the study, the ratings of every fifth video were compared and
discussed by the raters (but not changed afterwards).
Participants and therapists
The study examined 30 videotapes of seven therapists and eight patients: two to three of 41
videotapes were randomly selected for each patient, including one of the 12 CPT core sessions
and at least one from the subsequent additional sessions.
The patients were all women with a mean age of 31.13 years (SD = 7.7; range 22–43). The
PTSD diagnosis was related to CPA in two cases and to CSA in six cases. All of the patients
met at least three criteria for BPD. They also had been diagnosed with two to five co-morbid
mental disorders, typically major depression and/or anxiety disorders according to the SKID
I interview (Wittchen et al., 1997). All of the therapists were clinical psychologists who had
been trained in CPT by the developer, P. Resick, in a 5-day workshop and were supervised on
a weekly basis. Neither the supervisors nor the therapists received feedback regarding their
adherence ratings.
Statistical analysis
The inter-rater reliability coefficients were determined by calculating the intraclass correlation
coefficient (ICC) using Model 2 [ICC(2,1)], with ICCs exceeding 0.75 considered good. Item
4 includes 15 session-specific items. Each session-specific item includes four to seven sub-
items, depending on the content of the treatment session. We calculated the ICC for item
4 based on the mean value of all session-specific items. The ICC for the total adherence
score was calculated based on the total sum score of items 1–9. Cronbach’s α coefficient was
used to test the internal consistency of all items using a 3-point Likert scale (items 5 and 6
were excluded due to the different scaling that resulted from their orientation on the original
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Table 1. Frequency with which each session had been rated within
the 30 ratings
Session Frequency
























CPT Therapists’ Adherence Protocol; item 10 was also excluded). All of the analyses were
conducted using IBM SPSS, version 22.
Results
Items 1–3 and 5–10 were rated in every session. The contents of item 4 varied depending
on the respective session number. The frequency with which each CPT session was rated is
presented in Table 1. The inter-rater reliability for the total adherence score was high, with
ICC = 0.95. All ICCs and the mean, standard deviation (SD) and range for all items and for
the expert ratings are presented in Table 2.
The Cronbach’s α coefficient was .56. Three items generated low coefficient values and
contributed to a slightly lower total score: item 7 (cognitive approach and reference to
the PTSD disorder model; α = .60), item 8 (time management α = .65) and item 9
(implementation of interventions from treatments other than CPT; α = .61). However, no item
was removed from the scale because of each item’s importance with respect to its content and
similarity to the original CPT Therapists’ Adherence Protocol. The three experts considered
all the items relevant and appropriate, with M = 2.60 (SD = 0.15; range: 1–3) for relevance
and M = 2.61 (SD = 0.37; range 1–3) for appropriateness.
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Table 2. Intraclass correlation coefficient, range, mean and standard deviation of items and mean and
standard deviation of expert ratings for the CPT Adherence Rating Scale
Relevance Appropriateness
Item ICC(2,1) Mean (SD) Min/Max Mean (SD) Mean (SD)
1. Agenda .968∗ 0.85 (0.85) 0/2 2.0 (1.0) 2.67 (0.58)
2. Problematic behaviour
since last session
1.0 0.97 (0.99) 0/2 2.33 (0.58) 2.33 (1.16)
3. Dealing adherently with
problematic behaviour
1.0 0.93 (0.98) 0/2 2.67 (0.58) 3.0 (0.0)
4. Implementation of
intended interventions
.921∗ 1.53 (0.42) 1/2 3.0 (0.0) 2.88 (0.21)
5. Essential but not unique
elements
a. Established rapport .703∗ 4.13 (0.66) 3/5 3.0 (0.0) 2.67 (0.58)
b. Homework .911∗ 3.40 (1.14) 1/5 3.0 (0.0) 3.0 (0.0)
c. Structure and
time-use
.796∗ 3.12 (0.75) 2/5 2.67 (0.58) 3.0 (0.0)
6. Proscribed elements
a. Problems led to
departure from
agenda
1.0 0.30 (0.18) 0/1 2.67 (0.58) 2.0 (1.0)
b. Interventions not
included in manual
.794∗ 0.05 (0.20) 0/1 2.67 (0.58) 2.67 (0.58)
c. Off task discussion 1.0 0.07 (0.25) 0/1 2.67 (0.58) 2.33 (1.16)
7. Cognitive approach and
reference to the PTSD
disorder model
.871∗ 1.68 (0.45) 1/2 3.0 (0.0) 2.0 (0.0)
8. Time management .985∗ 1.18 (0.75) 0/2 2.67 (0.58) 2.67 (0.58)
9. Interventions from
different forms of therapy
.820∗ 1.67 (0.53) 1/2 1.67 (1.53) 2.33 (1.16)
10. Overall session
adherence
.910∗ 3.88 (0.93) 2/6 2.33 (0.58) 2.0 (1.0)
Total adherence score .945∗ 21.97 (4.58) 14/30
ICC(2,1) = intraclass correlation coefficients for both raters; Min = lowest score on the ratings on a
scale from 0 to 2 for items 1, 2, 3, 4, 7, 8 and 9; 1 to 5 for item 5; 0 to 1 for item 6, and 0 to 6 for item
10; Max = highest score on a scale from 0 to 2 for items 1, 2, 3, 4, 7, 8 and 9; 1 to 5 for item 5; 0 to
1 for item 6, and 0 to 6 for item 10. Relevance and appropriateness were assessed on a scale ranging
from 0 to 3. ∗p < .001.
Discussion
The results indicate that the newly developed ARS-CPT for our adapted CPT with
more flexible sessions for patients with PTSD after CSA/CPA and borderline personality
symptoms demonstrates good psychometric properties and is relevant and useful for assessing
therapeutic adherence in future PTSD treatment studies with modified CPT versions using
video ratings.
The results indicate excellent rater accordance for the entire scale and the individual
items. Explanations for the particularly high ICCs of 1 could be the clear instructions in
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the CPT manual, the restricted response scales and the high familiarity of the raters with
the ARS-CPT.
The internal consistency of the ARS-CPT was less satisfactory than expected, particularly
for several items. One reason for the relatively low consistency score might be the restricted
variance in the small and homogeneous sample. Because Cronbach’s α depends on the length
of the scale (Cortina, 1993), for the seven items using a 3-point Likert scale, the internal
consistency was acceptable (Cortina, 1993).
In future trials, it might be helpful to assess item 4 (‘Implementation of intended
interventions’) using distinct items to avoid being forced to compute a mean value that
might have reduced internal consistency. Another advantage of using distinct items could
be that session-specific elements, which are now mostly collapsed into one item (item 4), may
contribute more to the total ARS-CPT score.
Additionally, using only one Likert scale for all items would extend the items considered for
Cronbach’s α and might augment its value but at the cost of deviating from the original CPT
Therapists’ Adherence Protocol. Another important point is that other intervention studies
have obtained similar results for Cronbach’s α (e.g. Gutermann et al., 2015), which raises the
question whether Cronbach’s α is applicable to an adherence measure that assesses related
but independent therapist actions rather than a single, unidimensional construct.
The ARS-CPT seems to have good content validity because the experts considered all of the
items to be relevant and appropriate. In addition, the ratings were completed in an appropriate
time, with an average completion time of 10 min.
Limitations
Repeated ratings by the same therapist treating the same patient may have artificially increased
the inter-rater concordance in our study. Another limitation is the use of four different
Likert response scales, which, for example, restricted the items considered for the internal
consistency evaluation. The decision to remain as close to the original CPT Therapists’
Adherence Protocol as possible resulted in the use of different response scales (e.g. a 2-point
Likert scale for item 6 and a 5-point Likert scale for item 5). For the newly developed items,
we used a 3-point Likert response scale oriented on the response scales used in previous
studies that assess global aspects of therapeutic adherence (e.g. Gutermann et al., 2015).
The sample of 30 videotapes was small. Therefore, the results should be confirmed using a
larger sample of patients and therapists, which also would facilitate additional analysis, such
as regarding the possible factor structure and the predictive value of the scale. In addition,
the association of the presented scale with an assessment of therapeutic competence should
be examined in future studies to ensure that each measure different aspects. In particular,
item 5 (‘Established rapport’, ‘Reviewed the homework and discussed barriers to completing’
and ‘Structured the session and used time effectively’) might be confounded with therapeutic
competence.
An additional limitation concerns the independence of the raters and experts. Both raters
and two experts were involved in the treatment study because our adaption of the original
CPT protocol is a relatively new treatment and only a few experts had full insight into its
structure. Moreover, the raters were highly trained, which is time consuming and costly. The
need to extensively train raters might impede the scale’s future use. Nonetheless, for adherence
assessment, an excellent knowledge of the manual is indispensable (Barber et al., 2007).
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Considering the findings in previous studies that non-experts could also assess adherence
(Weck et al., 2011b), future studies should examine whether raters who were not involved in
the scale’s development would also achieve such high rater concordance.
Furthermore, the transferability of the results is limited by the homogeneity of our patient
sample because all of the patients were female and most had experienced CSA. This
characteristic could also result in restricted variance, which could affect the statistical analysis.
Finally, another limitation could be related to the aim of our study, which was to create an
adherence rating scale that could be used flexibly to assess different ways of administering
CPT. One disadvantage of this approach could be that the scale does not include items that
refer to specific problems resulting from frequent co-morbidities of PTSD, such as BPD in
our study. Future studies could aim to develop adherence items that focus more on the specific
treatment elements that address PTSD patients’ co-morbidities, such as alcohol abuse, BPD
or psychosis.
Apart from these limitations, our findings suggest that the ARS-CPT is a reliable,
appropriate instrument for assessing therapeutic adherence, which is important for future trials
with CPT. The ARS-CPT instrument will be helpful for accurately interpreting the results of
these studies, analysing possible effects of adherence on treatment outcomes and improving
therapeutic skills training.
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